Author(s)

Md. Sohel Rana¹, Md. Maruf Hasan², Md. Eshak Enan², Fatema-Tuz Zohora^1,2, A. T. M. Zafrul Azam¹

¹Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
²Department of Pharmacy, Primeasia University, 9 Banani C/A, Dhaka, Bangladesh.

Coronavirus infectious disease 2019 (COVID-19) first reported in Wuhan, China, causes serious respiratory illnesses such as lung failure and pneumonia. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) the pathogenic agent of COVID-19 has been confirmed as a novel coronavirus. WHO announced COVID-19 a global pandemic and now the whole world is eagerly waiting for vaccines and therapeutic treatment to get rid of this unstoppable coronavirus. As COVID-19 infection, a global threat creates unwanted human casualties and serious economic loss. To stop the ongoing uncontrolled situation researchers are racing to develop prevention and treatment strategies. Vaccines of different countries are in clinical and preclinical trials and the repurposed-drugs are providing to find out a positive result against COVID-19. The report is an analysis of published information focusing on treatment options including vaccination, drug-therapy, cytokines, therapeutic antibodies. Most of the vaccine’s development strategies and drugs target the surface structural spike glycoprotein or S-protein, the major inducer of pathogenic responses. Here, it is reviewed the features of SARS-CoV-2 and the global current status of therapeutic, and vaccine development for the prevention and effective treatment of COVID-19.

COVID-19, Epidemiology, Therapeutic, Vaccine, S Protein

Rana, M. , Hasan, M. , Enan, M. , Zohora, F. and Azam, A. (2021) Overview of an Emerging Coronavirus Infection, COVID-19: Current Status of Vaccine Development and Therapeutics. Pharmacology & Pharmacy, 12, 25-41. doi: 10.4236/pp.2021.121003.